MENU

Click here to

×

Are you sure ?

Yes, do it No, cancel

DISCLAIMER:
Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # | show all

Keywords: Treatment Verification
BReP-SNAP-T-24An Investigation of Using Logfile Analysis for Automated Patient Specific Quality Assurance in MRgRT
S Lim1*, P G Scripes1, M Napolitano2, E Subashi1, N Tyagi1, L Cervino 1, D Lovelock1, (1) Memorial Sloan-Kettering Cancer Center, New York, NY, (2) Standard Imaging, Middleton, WI
BReP-SNAP-T-50Dosimetric Sensitivity to Sources of Uncertainties for Liver Cancer and Trigeminal Neuralgia Treated with Ablative Radiosurgery
M Liu1*, J E Cygler2,1,3, J Doody2, S Malone2, J Pantarotto2, D Tiberi2, E Vandervoort2,1,3, (1) Carleton University, Ottawa, ON, CA, (2) The Ottawa Hospital Cancer Centre, Ottawa, ON, CA, (3) University of Ottawa, Ottawa, ON, CA
BReP-SNAP-T-55Electromagnetic Tracking as a Quality Assurance Tool for Complex Intracavitary and Interstitial Cervix Brachytherapy Implants
I Kolkman-Deurloo1*, M Doorn Van1, L Heerden Van1, J Schiphof-godart1, D Schaart2, M Hoogeman1, (1) Erasmus MC - Cancer Institute, Rotterdam, NL, (2) Delft Univ of Technology, Delft, NL
BReP-SNAP-T-57Error Detection and Classification in Patient Specific IMRT QA with Dual Neural Networks
N Potter*, K Mund, J Andreozzi, J Li, C Liu, G Yan, University of Florida, Gainesville, FL
BReP-SNAP-T-62Examining the Capability of Versa HD to Accurately Treat Single-Isocenter Multi-Lesion Brain Patients
R McGurk1*, E Schreiber1, M Dance1, S Stathakis2, K Zourari3,4, G Kalaitzakis3,5, E Zoros3,4, E Pappas3,6, B Read7, P Barry7, N Papanikolaou2, S Das1, P Mavroidis1, (1) University of North Carolina at Chapel Hill, Chapel Hill, NC, (2) Mays Cancer Center - MD Anderson Cancer Center, San Antonio, TX, (3) 3RTsafe P.C., Athens, Greece, (4) Medical Physics Laboratory, Medical School, National and Kapodistrian University of Athens, Athens, Greece, (5) Department of Medical Physics, University of Crete, Heraklion, Greece, (6) Radiology & Radiotherapy Sector, Department of Biomedical Sciences, University of West Attica, Athens, Greece, (7) Oncology Solutions, Elekta AB
BReP-SNAP-T-126Sub-Millimeter Range Monitoring in Heavy-Ion Therapy with Filtered Interaction Vertex Imaging (IVI)
D Hymers1*, E Kasanda1, V Bildstein1, J Easter1, A Spyrou2, C Hoehr3, D Muecher1,3, (1) University of Guelph, Guelph, ON, CA, (2) National Superconducting Laboratory, Michigan State University, East Lansing, MI (3) TRIUMF, Vancouver, BC, CA
MO-E-TRACK 2-3First Imaging of Intrinsic Light Emission From Biological Tissue Visualized Proton Pencil Beam Scanning
P Bruza1*, R Zhang1,2, Y Lin3, M Rahman1, B Pogue1,4, (1) Dartmouth College, Hanover, NH, (2) Dartmouth Hitchcock Medical Center, Lebanon, NH, (3) Emory University, Atlanta, GA, (4) DoseOptics LLC, Lebanon, NH
PO-GeP-M-75Automated Detection of Field Match Lines Between Supraclavicular and Tangent Irradiation Fields with Cherenkov Imaging
R Hachadorian1*, C Farwell2, M Jermyn2, D Gladstone1,3, L Jarvis3, B Pogue1,2,3, (1) Dartmouth College, Hanover, NH, (2) DoseOptics LLC, Lebanon, NH, (3) Dartmouth-Hitchcock Med. Ctr., Lebanon, NH.
PO-GeP-M-101Clinical Utility of External and Internal Surrogates for Respiratory Motion Management in Pancreas SBRT
A Briggs1*, B Zwan1,2, G Angelis1, M Shepherd1, A Kneebone1,3, G Hruby1,3, J Booth1,4, (1) Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, AU (2) School of Mathematical and Physical Sciences, University of Newcastle, Newcastle, AU (3) University of Sydney, Sydney, AU (4) School of Physics, Univeristy of Sydney, Sydney, AU
PO-GeP-M-201Evaluation of Liver Motion in Real Time Using Diaphragm Tracking Versus Tracking Implanted Gold Markers for Stereotactic Ablative Radiation Therapy (SAbR)
N Hassan Rezaeian1*, (1) The University of Texas Southwestern Medical Ctr, Dallas, TX
PO-GeP-M-384Statistical Process Control Analysis of Adaptive Patient Specific QA On the Elekta Unity MRI-Linac
S Strand*, A Boczkowski, J Snyder, D Hyer, S Yaddanapudi, D Dunkerley, J St-Aubin, University of Iowa, Iowa City, IA
PO-GeP-P-97Best Practice Guidance for Patient-Specific Quality Assurance for IMRT and VMAT Plan Delivery Verification
G Chan1*, A Abdellatif2, J Bissonnette3, L Chin4, D Comsa5, D Granville6, J Kraus Himmelman7, J King8, P Rapley9, A Vandermeer10, (1) Juravinski Cancer Center, Hamilton, ON, CA, (2) R.S. McLaughlin Durham Regional Cancer Centre, Oshawa, ON, CA, (3) Princess Margaret Cancer Centre, Toronto, ON, CA, (4) Odette Cancer Centre, Toronto, ON, CA, (5) Stronach Regional Cancer Centre, Newmarket, ON, CA, (6) The Ottawa Hospital, Ottawa, ON, CA, (7) Ontario Health (Cancer Care Ontario), Toronto, ON, CA, (8) Simcoe Muskoka Regional Cancer Centre, Barrie, ON, CA, (9) Thunder Bay Regional Health Sciences Center, Thunder Bay, ON, CA, (10) R.S. McLaughlin Durham Regional Cancer Centre, Oshawa, ON, CA
PO-GeP-T-18A Database-Driven Verification System for CT Simulation, Contouring and Plan Optimization
M Ayles*, P Munger, D Martin, M Brunet-Benkhoucha, G Jarry, L Archambault, Hopital Maisonneuve-Rosemont, Montreal, QCCA,
PO-GeP-T-87Adaptive Planning, Yes Or No: On Lung SBRT Tumors with Large Shifts During Daily Image Guidance
T Ma*, C Liu, S Ahmed, N Yu, P Qi, K Stephans, G Videtic, P Xia, The Cleveland Clinic Foundation, Cleveland, OH
PO-GeP-T-181Checking Sanity and Integrity of Treatment Plans in MR-Linac Based Adaptive Radiotherapy
P Zhang*, J Xiong, S Burleson, A Li, J Mechalakos, N Tyagi, Memorial Sloan-Kettering Cancer Center, New York, NY
PO-GeP-T-185Clinical Evaluation of An Automated Adaptive Proton Therapy Workflow Using Contour Propagation and Dose Evaluation
V T Taasti*, F Vaassen, C Hazelaar, A Vaniqui, W Van Elmpt, R Canters, M Unipan. Maastro Clinic, Maastricht, The Netherlands
PO-GeP-T-508Improved Prediction of MLC and Gantry Errors During VMAT Delivery Utilizing An Artificial Neural Network
I Hajizadeh*, M Price, A Yock, Vanderbilt Univ. Medical Ctr., Nashville, TN
PO-GeP-T-641Plan Quality Assessment for Rectal Cancer Patients Using Prediction of Organ-At-Risk Dose Metrics
A Vaniqui*, R Canters, F Vaassen, C Hazelaar, I Lubken, K Kremer, C Wolfs, W Van Elmpt, Maastro, Maastricht, NL,
PO-GeP-T-656Preliminary Clinical Analysis with Dose-Averaged LET Calculation for Head and Neck Cancer Patients Treated by Using Carbon-Ion Radiotherapy
S Lee1*, A Yamamoto1, K Yamaoka1, E Hotta1, M Yamamoto1, Y Suzuki2, A Inomata2, M Suga3, M Koto1, R Kohno1, (1)National Institutes for Quantum and Radiological Science and Technology, Chiba, JP (2)Accelerator Engineering Corporation, Chiba, JP (3)Kanagawa Cancer Center, Kanagawa, JP
PO-GeP-T-676Quantified VMAT Plan Complexity in Relation to Measurement-Based Quality Assurance Results
M Nguyen*, G Chan, Juravinski Cancer Center, Hamilton, ON, CA
PO-GeP-T-702Relationship Between Yttrium 90 Radioactivity Distribution and Treatment Response in Transarterial Radioembolization of Hepatocellular Carcinoma, An Institutional Study Results
C Adcock*, E Florez, A Patel, C M. Howard, A Fatemi, H Khosravi, University of Mississippi Medical Center, Jackson, MS
PO-GeP-T-713SABR Pre-Treatment Verification of Multiple Dosimeters (alanine, PTW60019, NanoDot, and TLD100H)
N Esen1*, P Ramachandran2, P Archer1, M Geso4, (1) Peter MacCallum Cancer Centre,Victoria,Australia, (2) Princess Alexandra Hospital, Brisbane, QLD,Australia. (3) RMIT University, Medical Radiations Science Discipline.
PO-GeP-T-759The Correlation of MLCleaf Trajectory Errors and Gamma Passing Rates of Patient-Specific ArcCheck-Based QA for Varian TrueBeam VMAT
Y Watanabe*, L Claps, University of Minnesota, Minneapolis, MN
PO-GeP-T-812Treatment Verification in Prostate Brachytherapy Patients Using Electromagnetic Tracking Integrated in An HDR/BT Afterloader
I Kolkman-Deurloo*, L Heerden Van, R Paassen Van, J Schiphof-godart, M Christianen, J Mens, M Franckena, M Maenhout, R Rijnsdorp, L Luthart, M Hoogeman, Erasmus MC - Cancer Institute, Rotterdam, NL
WE-A-TRACK 3-6Noise Reduction of Proton-Acoustic Signal for Proton Range Verification Using Stacked Auto-Encoder (SAE)
J Sohn1*, Y Lei1, W Nie2, S Avery3, X Yang1, T Liu1, (1) Emory University, Atlanta, GA, (2) University of Nebraska, Omaha, NE, (3) University of Pennsylvania, Philadelphia, PA
WE-B-TRACK 3-4Submillimeter Range Verification in Proton Therapy with a Hadron Tumour Marker (HTM)
C Burbadge1*, E Kasanda1, V Bildstein1, H Behnamian1, C Belanger-Champagne2, C Hoehr2, D Muecher1,2, (1) University of Guelph, Guelph, ON, Canada(2) TRIUMF, Vancouver, BC, Canada